Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2025-12-28 @ 8:07 AM
Study NCT ID:
NCT01601535
Status:
COMPLETED
Last Update Posted:
2019-07-31
First Post:
2012-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of MLN8237 in Combination With Irinotecan and Temozolomide
Sponsor:
New Approaches to Neuroblastoma Therapy Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
None
Primary Completion Date:
2018-07-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-25
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-11
First Submit QC Date:
None
Study First Post Date:
2012-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-30
Results First Submit QC Date:
None
Results First Post Date:
2019-07-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-10
Last Update Post Date:
2019-07-31
Last Update Post Date Type:
ACTUAL